Prostate carcinoma LNCaP cells were unique among several human cancer cell lines which include two other prostate cancer cell lines, PC-3 and DU-145, in expressing α1,2-L-fucosyltransferase (FT) as an exclusive FT activity. Affinity gel-GDP and Sephacryl S100 HR columns were used for a partial purification of this enzyme from 3.9 × 10 9 LNCaP cells (~200-fold; 40% yield). The K m value (2.7 mM) for the LacNAc type 2 acceptor was quite similar to the one reported for the cloned blood group H gene-specified α1,2-FT [Chandrasekaran et al. (1996) Biochemistry 35, 8914-8924]. N-Ethylmaleimide was a potent inhibitor (K i 12.5 µM). The enzyme showed four-fold acceptor preference for the LacNAc type 2 unit in comparison to the T-hapten in mucin core 2 structure. Its main features were similar to those of the cloned enzyme: (1) C-6 sulfation of terminal Gal in the LacNAc unit increased the acceptor efficiency, whereas C-6 sialylation abolished acceptor ability; (2) C-6 sulfation of GlcNAc in LacNAc type 2 decreased by 80% the acceptor ability, whereas LacNAc type 1 was unaffected; (3) Lewis x did not serve as an acceptor; (4) the C-4 hydroxyl rather than the C-6 hydroxyl group of the GlcNAc moiety in LacNAc type1 was essential for activity; and (5) the acrylamide copolymer of Galβ1,3GlcNAcβ-O-Al was the best acceptor among the acrylamide copolymers. Additionally, highly significant biological features of α1,2FT were identified in the present study. The synthesis of Globo H and Lewis b determinants became evident from the fact that Galβ1,3GalNAcβ1,3Galα-O-Me and Galβ1,3(Fucα1,4)Glc-NAcβ1,3Galβ-O-Me served as highaffinity acceptors for this enzyme. Further, D-Fucβ1,3Gal-NAcβ1,3Galα-O-Me was a very efficient acceptor, indicating that the C-6 hydroxyl group of the terminal Gal moiety in Globo H is not essential for the enzyme activity. Thus, the present study was able to demonstrate three different catalytic roles of LNCaP α1,2-FT, namely, the expressions of blood group H, Lewis b from Lewis a, and Globo H.
Introduction
A characteristic feature of tumor progression in distal colon and rectum is the expression of the blood group determinants Lewis b, H-type 2, and Lewis y, which contain the common motif Fucα1,2Galβ-R (Yuan et al., 1985; Hakomori, 1989; Itzkowitz, 1992 ). An increase of α1,2-fucosyltransferase (FT) activity was also found in colon cancer (Orntoft et al., 1991; Yazawa et al., 1993; Sun et al., 1995) . The H gene, which is overexpressed in colon cancer tissues, is the gene responsible for the synthesis of H blood group antigen of erythrocytes (Sun et al., 1995) . Goupille et al. (1997) transfected a weakly tumorigenic clone derived from a rat colon carcinoma cell line with the cDNA encoding for the human H FT and found that the expression of α1,2-fucosylated structures on a variant of CD44 adhesion molecule may be responsible for the aggressiveness of colon carcinoma cells.
Globo H is another structure containing Fucα1,2Galβ-and has been found at the cancer cell surface as a glycolipid and as glycoprotein (Bremer et al., 1984; Menard et al., 1983; Livingston, 1995; Adobati et al., 1997) . Globo H has been characterized by immunohistochemistry using the murine monoclonal antibody MBr1 (Bremer et al., 1984; Zhang et al., 1997) . There is enhanced expression of MBr1-positive antigens on both primary and metastatic prostate cancer specimens (Zhang et al., 1998) . Slovin et al. (1999) showed that Globo H is one of several candidate antigens present in prostate cancer cells that can serve as targets for immune recognition and treatment strategies.
An examination of several cancer cell lines by this laboratory revealed that the breast cancer cell line MCF-7 and the prostate cancer cell line LNCaP expressed α1,2-FT activity. Both α1,2-and α1,3-FT activities were found in MCF-7. In contrast to two other prostate cancer cell lines, DU145 (Mickey et al., 1977) and PC-3 (Kaighn et al., 1979) expressing α1,3-FT activity, LNCaP expressed exclusively α1,2-FT activity. Furthermore, LNCaP has been shown to maintain the characteristics of prostate carcinoma synthesizing secretory human prostatic acid phosphatase and organ-specific prostate antigen responding to sex hormones and containing the y chromosome (Horoszewicz et al., 1983) . In view of the fact that Globo H Fucα1,2Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glc is overexpressed in prostate cancer, it is of interest to study α1,2-FT, which is expressed by prostate cancer cells. The present article deals with partial purification and characterization of α1,2-L-FT present in LNCaP cells.
Results and discussion

Identification of α1,2-L-FT as an exclusive FT activity in LNCaP cells
The FT activities of LNCaP cells were compared with those of two other prostate cancer cell lines DU145 and PC3, the breast cancer cell line MCF-7 and the ovarian teratocarcinoma cell line PA-1 by using a number of synthetic acceptors (see Table I ). The use of Galβ-O-Bn, which is a specific acceptor for measuring α1,2-L-FT, indicated that only LNCaP and MCF-7 expressed α1,2-FT. DU145, PC-3 and PA-1 were active toward Galβ1,4GlcNAcβ-O-Al and were almost inactive toward Galβ1,3GlcNAc, indicating that they express exclusively α1,3-L-FT activity. MCF-7 showed more than fivefold activity toward Galβ1,4GlcNAcβ-O-Al as compared to its activity with Galβ-O-Bn, indicating that α1,3-and α1,2-L-FT activities were the major and minor activities, respectively. On the other hand, LNCaP utilized the acceptors Galβ-O-Bn, Galβ1,3GlcNAc, and Galβ1,4GlcNAc and their glycosides to the same extent, indicating that α1,2-L-FT is the only fucosylating activity in LNCaP cells. In support of this contention, LNCaP was almost inactive toward the acceptors specific for measuring α1,3-and α1,4-L-fucosylating activities such as NeuAcα2,3Galβ1,4GlcNAcβ-O-Bn, 2-O-MeGalβ1,3GlcNAcβ-O-Bn, and so on (see Table I ). But LNCaP exhibited high activity (148.3%) toward 6-OSulfoGalβ1,3GlcNAcβ-O-Al, which had been shown earlier by our laboratory (Chandrasekaran et al., 1996) as a highaffinity acceptor for the cloned α1,2-L-FT.
Partial purification and acceptor-substrate specificity analysis of α1,2-L-FT uniquely expressed by LNCaP cells
The enzyme has been purified ~200 fold with 40% recovery (Table II) by using Triton X-100 extraction, affinity Gel-GDP chromatography, and then fractionation on Sephacryl S-100 HR column. When the final purified enzyme preparation was examined with various synthetic compounds as acceptors (Table III) , it was found that LacNAc types 1 and 2 were better than blood group T-hapten (Galβ1,3GlcNAcβ-O-Al: 120.0%; Galβ1,4GlcNAcβ-O-Al: 97.9% and Galβ1,3GalNAcα-O-Al: 64.8%). Replacement of terminal β-Gal with βGalNAc resulted in loss of activity (GalNAcβ1,4GlcNAcβ-O-Bn: 2.8%). Compounds with terminal α-Gal did not serve as acceptors. The GlcNAc moiety of LacNAc structure has influence on the enzyme activity (Galβ1,3GlcNAcβ-O-Al: 120.0%; Galβ1,3Galβ-O-Al: 42.8%). Furthermore, the C-4 OH of the GlcNAc moiety is essential for the enzyme activity (Galβ1,3[4-O-Me]GlcNAcβ-O-Bn: 13.8%; Galβ1,3[6-O-Me]GlcNAcβ-O-Bn: 88.3%; and Galβ1,3[4-6-di-O-Me]GlcNAcβ-O-Bn: 9.7%). As compared to T-hapten, the Globo H backbone structure was twofold more active (Galβ1,3GalNAcα-O-Al: 64.8%; Galβ1,3GalNAcβ1,3Galα-O-Me: 124.8%). Furthermore, we found that the C-6 OH group of the terminal Gal moiety in Globo H structure is not needed for the enzyme activity (DFucβ1,3GalNAcβ1,3Galα-O-Me: 142.1%). LacNAc structures in extended chains were quite active (Galβ1,3GlcNAcβ1,3Gal-β1,4Glc: 107.6%; Galβ1,4GlcNAcβ1,6Man-α1,6Manα1,6Man: 114.5%). Compounds containing terminal Lewis x structure were inactive (Galβ1, 4[Fucα1, 3] GlcNAcβ1,6Manα1,6Man: 2.1%; Galβ1, 4[Fucα1, 3] GlcNAc-β1,3Galβ-O-Me: 0%).
The most interesting observation was that β-glycosides of Lewis a were inactive acceptors, whereas Lewis a linked β1,3 to Gal was equally active as 3[Fucα1, In this context, it is important to note that GlcNAc substitution on C-3 OH of the terminal Gal moiety abolished the acceptor activity (GlcNAcβ1,3Galβ-O-Me: 0.1%; GlcNAcβ1,3Galβ1,4Glc: 1.4%); these data strongly suggest that Galβ1,3(Fucα1,4)GlcNAcβ1,3Galβ-O-Me is being α1,2 fucosylated on the terminal Gal moiety. As anticipated, LacNAc structure in mucin core 2 was found as a better acceptor than the Gal moiety linked β1,3 to
78.6%). It was also noticed that a terminal β1,6-linked GlcNAc moiety in mucin core 2 inhibits the enzyme activity
Among the acrylamide copolymers of allyl glycosides containing terminal β-Gal moiety, Galβ1,3GlcNAcβ-O-Al/AA-CP exhibited the highest affinity for the enzyme (39.3% activity at 0.05 mM concentration as compared to Galβ-O-Bn at 3.0 mM concentration).
Next, we examined the influence of sulfate or sialyl group on the enzyme activity using various sulfated or sialylated synthetic compounds (Table IV) Table IV ). The Globo H backbone structure on 3-O-sulfation of terminal Gal became an inactive acceptor (3-OSulfoGalβ1,3GalNAcβ1,3Galα-O-Me: 0.8%). Neither C-6 sulfation of the GlcNAc moiety nor C-3 sulfation of one of the terminal Gal moieties of the mucin core 2 acceptors had any appreciable influence on their acceptor activities, as was evident from a comparison of their acceptor efficiencies to that of the corresponding non-sulfated compounds (see Table IV ).
The kinetic properties of LNCaP α1,2-L-FT
Mg 2+ and Mn 2+ stimulated to a maximum of 100% the LNCaP α1,2-L-FT activity at 30 mM and 10 mM concentrations (Figure 1 ) respectively, whereas Ca 2+ stimulation was 50% at 20 mM. There was no inhibition of this activity by any of the divalent metal ions at the maximum concentration (50 mM) tested.
The pH optimum for this enzyme activity was found to be 6.8 (Figure 2) as demonstrated with two different acceptors, namely, Galβ1,4GlcNAcβ-O-Al and Galβ1,3GalNAcβ1,3Galα-O-Me. The two acceptors showed an identical pattern of activities over the pH range tested, indicating that the same enzyme utilizes both acceptors. An identical pattern of inhibition was Table IV . Acceptor-substrate specificity analysis of the purified α1,2-L-fucosyltransferase from human prostate carcinoma cells LNCap using sialylated or sulfated compounds as the acceptors This data strongly suggested that the same enzyme α1,2 fucosylates both LacNAc and Globo H backbone structures.
Demonstration of the enzyme specificity toward LacNAc structures
The [ 14 C] fucosylated products arising from the mucin core 2 acceptor containing two terminal Gal moieties (namely, Galβ1,4GlcNAcβ1,6(Galβ1,3)GalNAcα-O-Bn) were isolated by Sep-Pak C18 cartridge method and then subjected to fractionation on peanut agglutinin-agarose column (see Figure 4) . It was found that ~80% of the radioactive product exhibited specific binding to the column, indicating its structure as 14 C-Fucα1,2Galβ1,4GlcNAcβ1,6(Galβ1,3)GalNAcα-O-Bn and the remaining 20% as Galβ1,4GlcNAcβ1,6( 14 C-Fuc− α1,2Galβ1,3)GalNAcα-O-Bn. We found that the acceptor specificities of LNCaP α1,2-L-FT were quite identical to those of the cloned human blood group H gene-specified α1,2-L-FT reported earlier by our laboratory (Chandrasekaran et al., 1996) . The main features were as follows: (1) The K m values for LacNAc type 2 for both enzymes were almost the same (cloned enzyme:1.67 mM; LNCaP enzyme: 2.70 mM; (2) the specificities of both enzymes are directed mainly toward LacNAc structure (fourfold as compared to T-hapten Galβ1,3GalNAcα); (3) C6 sulfation of terminal Gal increased the acceptor efficiency, whereas C6 sialylation abolished the acceptor ability; (4) C6 sulfation of GlcNAc in LacNAc type 2 decreased ~80% the acceptor activity, whereas LacNAc type 1 was not affected at all; (5) Lewis x did not serve as an acceptor; (6) the C4 hydroxyl group but not the C6 hydroxyl group of the GlcNAc moiety in LacNAc type 1 is essential for the activity; and (7) Galβ1,3GlcNAcβ-O-Al/AA-CP served as the best acceptor among the various acrylamide copolymers examined.
The present study used additional novel synthetic acceptors and was able to decipher biologically highly significant unique catalytic abilities of this enzyme. The synthetic compounds Galβ1,3GalNAcβ1,3Galα-O-Me, D-Fucβ1,3GalNAcβ1,3Galα-O-Me, and Galβ1,3(Fucα1,4)GlcNAcβ1,3Galβ-O-Me served as high-affinity acceptors for this enzyme. Thus this enzyme has the potential to synthesize Globo H (namely, Fucα1,2Galβ1,3GalNAcβ1,3Galα-) and Lewis b in extended chain (namely Fucα1,2Galβ1,3(Fucα1,4)GlcNAcβ1,3Galβ-). Furthermore, this enzyme utilizes the compound D-Fuc− β1,3GalNAcβ1,3Galα-O-Me very efficiently as an acceptor, indicating that the C6 hydroxyl group of the terminal Gal moiety is apparently not essential for enzyme activity.
The construction of Fucα1,2Galβ-linkage known as H determinants is determined by the H and secretor blood group loci known as FUT 1 and FUT 2 respectively (Larsen et al., 1990; Kelly et al., 1995) . Sarnesto et al. (1992) ) gave evidence for a significant difference in the kinetic properties of the H-and secretor-type α1,2-L-FTs purified from human sera. Valli et al. (1998) studied α1,2-L-FT in human colon adenocarcinoma cell lines and suggested the involvement of secretor-type α1,2-L-FT in the biosynthesis of type 1 chain tumor-associated antigens in human colon carcinoma cells. Nishihara et al. (1999) reported that an augmented expression of Le b antigens in distal colon cancers was caused mainly by up-regulation of the secretor enzyme, and in proximal cancers, it is caused by the upregulation of the H enzyme alone, indicating that both enzymes are involved in cancer. The present study has demonstrated that LNCaP α1,2-L-FT can synthesize Lewis b from Lewis a and Globo H from Galβ1,3GalNAcβ1,3Galα-. Furthermore, our previous studies (Chandrasekaran et al., 1995 (Chandrasekaran et al., , 2001 ) have demonstrated that Lewis type FT (FT III) can synthesize Lewis b from Lewis a. Thus, the biosynthesis of Lewis b determinant and Globo H can be outlined in a scheme (Figure 7) .
We found in the present study that the LNCaP α1,2-FT could utilize both Galβ1,3GlcNAc and Galβ1,4GlcNAc resulting in type 1 and type 2 H structures. However, it could catalyze the synthesis of Lewis b from Lewis a, but not of Lewis y from Lewis x. The explanation for this discrepancy comes from the conformational analysis, as discussed.
The conformational analysis of Imberty et al. (1995) ) indicates that the torsion angle at the Galβ1,4GlcNAc linkage in the Lewis x trisaccharide has a maximum of -103.6, whereas this value for the Galβ1,3GlcNAc linkage in the Lewis a trisaccharide is 144.1. The maximum torsion angle at the Fucα1,3GlcNAc linkage is -150.7 and at the Fucα1,4GlcNAc linkage is -97.7. The research group further reported that, in contrast to Lewis x, a second conformational family exists in the case of the Lewis a trisaccharide, even if it is not energetically favored. They explained that when this conformational family occurs, it is correlated to a conformational change in the Fucα1,4GlcNAc linkage, resulting in a change of ψ value from -97.7 to -170.7. Pérez et al. (1996) studied the conformation of two crystallographic independent molecules of the Lewis x trisaccharide and found that these two molecules differ essentially in the torsion angles at their Galβ1,4GlcNAc linkages by 10°. This observation could suggest the possible existence of two or possibly more conformational species of the Lewis a trisaccharide differing in their glycosidic torsion angles at the Galβ1,3 GlcNAc linkage. Thus, all the conformational analysis data would indicate that the Lewis a trisaccharide exhibits a conformation that is favorable for enzymatic action leading to the formation of the Fucα1,2 Gal linkage. Additionally, in support of this contention, we have very recently found that gastric carcinoma α1,2-FT can utilize Galβ1,3(Fucα1,4)GlcNAcβ1,3Galβ-O-Me but not Galβ1,4(Fucα1,3)GlcNAcβ1,3Galβ-O-Me as an acceptor substrate (Chandrasekaran et al. unpublished data) . Now, we have shown that the synthesis of Lewis b is facilitated by the dual catalytic roles of α1,2-FT and α1,3/4-FT and that of Globo H by α1,2-L-FT, and these enzymes are encountered in normal tissues. It is tempting to conclude that the overexpression of these carbohydrate antigens in cancer is not caused by an aberrant or novel α1,2-L-FT but may be due to an overexpression of these normal enzymes in cancer. However, there is a possibility for the existence of an aberrant or novel α1,2-FT converting Lewis x to Lewis y, and this particular enzyme may also convert Lewis a to Lewis b.
Materials and methods
Cell culture
The breast carcinoma cell line MCF-7, the prostate cancer cell line DU 145, and the ovarian teratocarcinoma cell line PA-1 were grown in minimal essential medium. The prostate carcinoma cell lines LNCaP and PC-3 were grown in RPMI 1640 and Leibovitz's medium, respectively (all media were supplemented with 10% fetal bovine serum and the antibiotics penicillin, streptomycin, and emphtoericin B) in 250-ml T-flasks under conditions as recommended by the American Type Culture Collection. Furthermore, LNCaP cells were grown in 2-L roller bottles to obtain the large amount of cells needed for the purification of α1,2-L-FT. The cells were homogenized with 0.1 M Tris-Maleate, pH 7.2, containing 2% Triton X-100 and 0.1% NaN 3 using a Dounce all-glass hand-operated homogenizer. The homgenate was centrifuged at 16,000 × g for 1 h at 4°C. Protein was measured on the supernatants by the BCA micro method (Pierce Chemical) with bovine serum albumin as the standard. The supernatants were adjusted to 5 mg protein/ml by adding the necessary amount of extraction buffer and then stored frozen at -20°C until use.
Partial purification of α1,2-L-FT from human prostate carcinoma LNCaP cells
LNCaP cells (3.9 × 10 9 ) were homogenized with 30 ml of 0.1 M Tris-Maleate, pH 7.2, 2% Triton X-100, and 0.1% NaN 3 using a Dounce all-glass hand-operated homogenizer; subjected to mixing in the cold room using speci-mix for 2 h; and then centrifuged at 16,000 × g at 4°C. The pellet was rehomogenized with 20 ml of the extraction buffer, mixed for 1 h, and centrifuged as before. The combined supernatant was passed through affinity Gel-GDP (25 ml bed volume) that had been equilibrated with the extraction buffer. After the entry of the sample, the affinity column was washed with 75 ml of the extraction buffer and then eluted with 100 ml of the extraction buffer containing 0.5 mM GDP. The eluate was concentrated by Amicon ultrafiltration to 5 ml using PM10 membrane and dialyzed against 500 ml of the extraction buffer for 48 h at 4°C with three changes. The purified enzyme preparation was applied to a Sephacryl S-100 HR column (2.5 × 118.0 cm) at 4°C equilibrated and eluted with 0.1 M Tris-Maleate, pH 7.2, containing 0.1% Triton X-100 and 0.02% NaN 3 . Fractions of 2 ml at a flow rate of 6 ml/h were collected, and 10-µl aliquots of alternate fractions were used for measuring α1,2-L-FT activity using Galβ-O-Bn as the acceptor. The enzyme activity emerged as a single peak after the void volume. These fractions were pooled, concentrated, and dialyzed as described and then stored frozen at -20°C.
Synthetic compounds
We have already reported the synthesis of several compounds used in the present study (Jain et al., 1993 (Jain et al., , 1994 (Jain et al., , 1998 Chandrasekaran et al., 1995) . The chemical synthesis of Galβ1,3GalNAcβ1,3Galα-O-Me and D-Fucβ1,3GalNAc-β1,3Galα-O-Me will be reported elsewhere.
Assay of FT
The incubation mixtures run in duplicate contained 50 mM HEPES-NaOH, pH 7.5, 5 mM MnCl 2 , 7 mM ATP, 3 mM NaN 3 , the acceptor (3.0 mM unless otherwise stated), 0.05 µCi of GDP-[U-14 C]Fuc (specific activity 290 mCi/mmol) and enzyme in a total volume of 20 µl; the control incubation mixtures had everything except the acceptor. At the end of incubation for 2 h at 37°C, the mixture was diluted with 1.0 ml of water and passed through a Dowex-1-Cl column (1 ml in a Pasteur pipet) (Chandrasekaran et al., 1992) . The column was washed twice with 1 ml water; the breakthrough and wash that contained the [ 14 C] fucosylated neutral acceptor were collected together in a scintillation vial and the radioactive content was determined using 3a70 scintillation fluid (Research Products International, Mount Prospect, IL) and a Beckman LS9000 instrument. The Dowex column was then eluted with 3.0 ml of 0.2 M NaCl to obtain the [ 14 C] fucosylated product from sialylated/sulfated acceptors and then counted for radioactivity as described. Corrections were made by subtracting the radioactivity in the water and NaCl eluates of the control incubation mixtures from the values of the corresponding eluates of the tests. Duplicate samples did not vary more than 5%.
Effect of pH and divalent cations on LNCaP α1,2-L-FT
HEPES-NaOH buffer in the pH range 6.0-8.4 (final concentration in reaction mixture, 0.1 M) was used under the standard incubation conditions. For seeing the effect of divalent metal ions, the incubation mixture contained varying concentrations (0-50 mM) of Mg acetate, Mn acetate, or Ca acetate under standard incubation conditions.
Inhibition by N-ethylmaleimide
The enzyme was preincubated for 30 min at 37°C with varying concentration of NEM and then assayed under standard incubation conditions.
Testing for competitive inhibition
We took advantage of the fact that the radioactive product arising from the competitive acceptor, namely, the monosulfated compound, binds to the Dowex-1 column, whereas the product from the non-sulfated neutral acceptor can be washed out from the column with water. The concentration of the neutral acceptor was varied from 0 to 3.0 mM and that of the sulfated acceptor was kept constant (3.0 mM).
Peanut agglutinin-agarose affinity chromatography
A column of 5 ml bed volume of peanut agglutinin agarose (Vector Lab, Burlingame, CA) was employed using 10 mM HEPES, pH 7.5, containing 0.1 mM Ca 2+ , 0.01 mM Mn 2+ , and 0.1% NaN 3 as the eluting buffer as recommended by the manufacturer. The fractionation was done at room temperature. The [ 14 C] fucosylated product mixture from Galβ1,4GlcNAc-β1,6(Galβ1,3)GalNAcα-O-Bn was applied to the column in 1.0 ml of the buffer. After the entry of the sample into the column bed, it was allowed to remain in contact with the gel for 20 min before starting elution with the same buffer. Fractions of 1 ml were collected. The bound material was eluted with the same buffer containing 0.2 M galactose. Galβ1, 3GlcNAcβ1, Galβ1, 3(Fucα1, 4)GlcNAcβ1, Galβ1, 3GalNAcβ1, 3GalNAcβ1, 
Identification of the products arising from
by the action of LNCaP FT
Tenfold reaction mixtures (200 µl) containing each acceptor separately were incubated for 4 h at 37°C. After incubation the reaction mixtures were diluted with 1 ml water and then passed through Dowex-1-Cl as described. The breakthrough plus water eluates were lyophilized to dryness, dissolved in 1 ml water and then subjected to chromatography on a Biogel P-2 column (1.0 × 116 cm) utilizing 0.1 M pyridine acetate, pH 5.4, as the eluting buffer. Fractions appearing under the first peak containing the [ 14 C] fucosyl compound were pooled in each case, lyophilized to dryness and dissolved in 200 µl water. These radioactive samples were subjected to TLC on silica gel GHLF (Analtech, 250 microns, scored 20 cm × 20 cm) plates developed in the solvent system 1-propanol/NH 4 OH [25%]/water (12:2:5). The radioactive content of half-cm width segments scraped into scintillation vials and soaked in 2 ml water was determined by liquid scintillation spectroscopy. Autoradiography was carried out at -70°C using Biomax-MR film (Kodak) after spraying the TLC plate with EnHance (DuPont).
